Balancing the scale: the role of oral anticoagulants in atrial fibrillation
Atrial fibrillation is the most common recurrent arrhythmia worldwide, and can put patients at increased risk of stroke.
Breathing change into asthma care
Updated guidelines in the Australian Asthma Handbook were released in September 2025 with SABA-only therapy now considered risky in adults and adolescents.
From chemist to pharmacist and beyond …
Centenarian and PSA life member JSD ‘Stan’ Mellick OAM, ED, PhC, BA, PhD reflects on a 75-year association with pharmacy.
Should cannabidiol be down-scheduled to S3?
The Therapeutic Goods Administration (TGA) has delivered an interim decision to down-schedule low dose cannabidiol.
Antibiotic prescribing is reaching dangerous levels, warns report
Antibiotic use has crept back up since COVID-19 restrictions have lifted, with multi-resistant bugs increasingly in our midst.
Top five pharmacy Budget asks
The PSA has provided a blueprint to help Federal Treasurer Jim Chalmers improve primary care and enhance medicine safety for all Australians.
